Invion is developing a new Photodynamic Therapy (PDT), in which a light-sensitive drug is used to kill cancer cells. Invion’s PDT, called IVX-P02, has generated some interesting case studies and early clinical data, and the company is moving towards larger studies aimed at registration in Australia and New Zealand, possibly by 2021.